JP2020501519A5 - - Google Patents

Download PDF

Info

Publication number
JP2020501519A5
JP2020501519A5 JP2019523736A JP2019523736A JP2020501519A5 JP 2020501519 A5 JP2020501519 A5 JP 2020501519A5 JP 2019523736 A JP2019523736 A JP 2019523736A JP 2019523736 A JP2019523736 A JP 2019523736A JP 2020501519 A5 JP2020501519 A5 JP 2020501519A5
Authority
JP
Japan
Prior art keywords
seq
polyketide synthase
domain
pksb
orf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019523736A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020501519A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/058805 external-priority patent/WO2018081592A2/en
Publication of JP2020501519A publication Critical patent/JP2020501519A/ja
Publication of JP2020501519A5 publication Critical patent/JP2020501519A5/ja
Pending legal-status Critical Current

Links

JP2019523736A 2016-10-28 2017-10-27 化合物の生産のための組成物および方法 Pending JP2020501519A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662414435P 2016-10-28 2016-10-28
US62/414,435 2016-10-28
PCT/US2017/058805 WO2018081592A2 (en) 2016-10-28 2017-10-27 Compositions and methods for the production of compounds

Publications (2)

Publication Number Publication Date
JP2020501519A JP2020501519A (ja) 2020-01-23
JP2020501519A5 true JP2020501519A5 (cg-RX-API-DMAC7.html) 2020-12-10

Family

ID=62024069

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019523736A Pending JP2020501519A (ja) 2016-10-28 2017-10-27 化合物の生産のための組成物および方法

Country Status (8)

Country Link
US (1) US11479797B2 (cg-RX-API-DMAC7.html)
EP (1) EP3532633A4 (cg-RX-API-DMAC7.html)
JP (1) JP2020501519A (cg-RX-API-DMAC7.html)
KR (1) KR20190099396A (cg-RX-API-DMAC7.html)
CN (1) CN110506120A (cg-RX-API-DMAC7.html)
AU (1) AU2017350900A1 (cg-RX-API-DMAC7.html)
CA (1) CA3042231A1 (cg-RX-API-DMAC7.html)
WO (1) WO2018081592A2 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9428845B1 (en) 2010-12-28 2016-08-30 Warp Drive Bio, Inc. Identifying new therapeutic agents
US10533016B2 (en) 2015-01-09 2020-01-14 Revolution Medicines, Inc. Compounds that participate in cooperative binding and uses thereof
CA3000822A1 (en) 2015-10-01 2017-04-06 Warp Drive Bio, Inc. Methods and reagents for analyzing protein-protein interfaces
ES2921056T3 (es) 2016-04-12 2022-08-17 Warp Drive Bio Inc Composiciones y métodos para la producción de compuestos
CA3042231A1 (en) 2016-10-28 2018-05-03 Ginkgo Bioworks, Inc. Compositions and methods for the production of compounds
KR20220109408A (ko) 2019-11-04 2022-08-04 레볼루션 메디슨즈, 인크. Ras 억제제
EP4054720A1 (en) 2019-11-04 2022-09-14 Revolution Medicines, Inc. Ras inhibitors
CN115873067A (zh) 2019-11-04 2023-03-31 锐新医药公司 Ras抑制剂
CR20230165A (es) 2020-09-15 2023-06-02 Revolution Medicines Inc Derivados indólicos como inhibidores de ras en el tratamiento del cáncer
WO2022072718A1 (en) 2020-09-30 2022-04-07 Nobell Foods, Inc. Recombinant milk proteins and food compositions comprising the same
US10894812B1 (en) 2020-09-30 2021-01-19 Alpine Roads, Inc. Recombinant milk proteins
US10947552B1 (en) 2020-09-30 2021-03-16 Alpine Roads, Inc. Recombinant fusion proteins for producing milk proteins in plants
WO2022235870A1 (en) 2021-05-05 2022-11-10 Revolution Medicines, Inc. Ras inhibitors for the treatment of cancer
AR127308A1 (es) 2021-10-08 2024-01-10 Revolution Medicines Inc Inhibidores ras

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH074269B2 (ja) 1984-10-04 1995-01-25 サンド・アクチエンゲゼルシャフト シクロスポリン類に対するモノクロ−ナル抗体
DE69013742T2 (de) 1989-04-15 1995-03-23 Fujirebio Kk Peptide und diese Peptide enthaltende Wirkstoffe gegen Dementia.
EP0562853B1 (en) 1992-03-27 1996-06-05 American Home Products Corporation 29-Demethoxyrapamycin for inducing immunosuppression
DE69434408T2 (de) 1993-09-20 2006-03-16 The Leland Stanford Junior University, Palo Alto Recombinante Herstellung aromatischer Polyketiden
IL112873A (en) 1994-03-08 2005-03-20 Wyeth Corp Rapamycin-fkbp12 binding proteins, their isolation and their use
GB9410142D0 (en) 1994-05-20 1994-07-06 Univ Warwick Carbapenems
GB9524630D0 (en) 1994-12-24 1996-01-31 Zeneca Ltd Chemical compounds
US6124453A (en) 1995-07-04 2000-09-26 Novartis Ag Macrolides
CA2197524A1 (en) * 1996-02-22 1997-08-22 Bradley Stuart Dehoff Polyketide synthase genes
WO1998001546A2 (en) 1996-07-05 1998-01-15 Biotica Technology Limited Polyketides and their synthesis
SE9603465D0 (sv) 1996-09-23 1996-09-23 Astra Ab New compounds
US6902913B2 (en) 1997-04-30 2005-06-07 Kosan Biosciences, Inc. Recombinant narbonolide polyketide synthase
US6153383A (en) 1997-12-09 2000-11-28 Verdine; Gregory L. Synthetic transcriptional modulators and uses thereof
EP1079859B1 (en) 1998-05-22 2010-07-14 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
JP2002526114A (ja) 1998-10-02 2002-08-20 コーサン バイオサイエンシーズ， インコーポレイテッド ポリケチドシンターゼおよびその組換えｄｎａ構築物
US6686454B1 (en) 1998-10-09 2004-02-03 Isotechnika, Inc. Antibodies to specific regions of cyclosporine related compounds
AU2876300A (en) 1999-02-09 2000-08-29 Board Of Trustees Of The Leland Stanford Junior University Methods to mediate polyketide synthase module effectiveness
GB9927191D0 (en) 1999-11-17 2000-01-12 Angeletti P Ist Richerche Bio Methods and means for regulation of gene expression
AU1776501A (en) 1999-11-19 2001-05-30 Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and their use in the disruption of protein-protein interactions
US7220552B1 (en) 1999-11-19 2007-05-22 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and their use in the disruption of protein-protein interactions
AU784995B2 (en) * 2000-02-08 2006-08-17 Sinvent As Novel genes encoding a nystatin polyketide synthase and their manipulation and utility
AP2002002407A0 (en) 2000-05-23 2002-03-31 Vertex Pharma Caspase inhibitors and uses thereof.
US7198924B2 (en) * 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
US20030153053A1 (en) * 2001-08-06 2003-08-14 Ralph Reid Methods for altering polyketide synthase genes
US6809077B2 (en) 2001-10-12 2004-10-26 Enanta Pharmaceuticals, Inc. Cyclosporin analogs for the treatment of autoimmune diseases
US6987090B2 (en) 2002-05-09 2006-01-17 Lg Household & Health Care Ltd. Use of 3-position cyclosporin derivatives for hair growth
EP1477563A3 (en) 2003-05-16 2004-11-24 Wyeth Cloning genes from streptomyces cyaneogriseus subsp.noncyanogenus for biosynthesis of antibiotics and methods of use
CA2643826A1 (en) 2006-02-27 2008-06-12 Paul A. Wender Compositions and methods for transport of molecules with enhanced release properties across biological barriers
US20070203168A1 (en) 2006-02-28 2007-08-30 Zhao Jonathon Z Isomers of rapamycin and 42-Epi-rapamycin, methods of making and using the same
KR100945483B1 (ko) 2007-10-25 2010-03-05 이화여자대학교 산학협력단 ｐｉｋＤ 조절유전자의 발현벡터를 이용한 스트렙토미세스베네주엘라에（Ｓｔｒｅｐｔｏｍｙｃｅｓｖｅｎｅｚｕｅｌａｅ）에서폴리케타이드（ｐｏｌｙｋｅｔｉｄｅ）의 생산성 증가방법
GB0805363D0 (en) 2008-03-20 2008-04-30 Sinvent As Novel NRPS-PKS gene cluster and its manipulation and utility
WO2010031185A1 (en) 2008-09-19 2010-03-25 Protox Therapeutics Inc. Treating cancer stem cells using targeted cargo proteins
JP5789190B2 (ja) 2008-09-24 2015-10-07 シャンハイ インスティテュート オブ オーガニック ケミストリー，チャイニーズ アカデミー オブ サイエンシズ 新規の遺伝子クラスター
EP2391376A4 (en) 2009-01-30 2012-08-01 Enanta Pharm Inc ANALOGUES OF CYCLOSPORIN FOR PREVENTING OR TREATING HEPATITIS C INFECTION
JP2012532929A (ja) 2009-07-13 2012-12-20 プレジデント アンド フェロウズ オブ ハーバード カレッジ 二機能性のステープリングされたポリペプチドおよびそれらの使用
US8664186B2 (en) 2009-07-24 2014-03-04 Universite De Lorraine Stambomycin and derivatives, their production and their uses as drugs
US20130072439A1 (en) 2009-09-22 2013-03-21 Huw M. Nash Peptidomimetic macrocycles
EP2492344B1 (en) 2009-10-22 2016-04-06 PeptiDream Inc. Rapid display method in translational synthesis of peptide
CA3069819C (en) 2010-11-30 2022-07-26 The Johns Hopkins University Hybrid cyclic libraries and screens thereof
US9428845B1 (en) 2010-12-28 2016-08-30 Warp Drive Bio, Inc. Identifying new therapeutic agents
US9260484B2 (en) 2011-06-15 2016-02-16 Ohio State Innovation Foundation Small molecule composite surfaces as inhibitors of protein-protein interactions
PT2872157T (pt) 2012-07-12 2020-04-30 Hangzhou Dac Biotech Co Ltd Conjugados de moléculas de ligação celular com agentes citotóxicos
EP2922818B1 (en) 2012-11-24 2018-09-05 Hangzhou Dac Biotech Co., Ltd Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
EP2806274A1 (en) 2013-05-24 2014-11-26 AIT Austrian Institute of Technology GmbH Lung cancer diagnostic method and means
US10233431B2 (en) 2014-02-26 2019-03-19 The Regents Of The University Of California Producing 3-hydroxycarboxylic acid and ketone using polyketide synthases
CN106255882A (zh) 2014-03-03 2016-12-21 耶路撒冷希伯来大学伊森姆研究发展公司 用于检测铜绿假单胞菌的方法和装置
CA3042231A1 (en) 2016-10-28 2018-05-03 Ginkgo Bioworks, Inc. Compositions and methods for the production of compounds

Similar Documents

Publication Publication Date Title
JP2020501519A5 (cg-RX-API-DMAC7.html)
JP5608372B2 (ja) 耐熱性カタラーゼ
JP2011512144A5 (cg-RX-API-DMAC7.html)
JP2007502124A5 (cg-RX-API-DMAC7.html)
DK2041276T3 (da) Fremgangsmåde til fremstilling af l-aminosyrer ved hjælp af mutanter af glta-genet kodende for citrat synthase
DK1885850T3 (da) Fremgangsmåde til fremstilling af D-psicose ved D-psicose-epimerase
JP2011224002A5 (cg-RX-API-DMAC7.html)
JP2014083054A5 (cg-RX-API-DMAC7.html)
RU2015112079A (ru) Композиции и способы, имеющие отношение к мутантному токсину из Clostridium Difficile
RU2011152925A (ru) Полипептид, обладающий активностью d-лактатдегидрогеназы, полинуклеотид, кодирующий этот полипептид, и способ получения d-молочной кислоты
RU2009148322A (ru) Новые гены ацилтрансферазы лизофосфатидной кислоты
CN110892067A (zh) 热稳定性提高的phi29DNA聚合酶突变体
CN104093836B (zh) 烃合成酶基因及其利用
JP2018102287A (ja) イミダゾールジペプチド合成活性を有するタンパク質及びイミダゾールジペプチドの製造方法
JP2007074939A5 (cg-RX-API-DMAC7.html)
JP7092355B2 (ja) 増殖とタンパク質生成との分離
CN104673814B (zh) 一种来自于阴沟肠杆菌的l‑苏氨酸醛缩酶及其应用
JP2018537111A5 (cg-RX-API-DMAC7.html)
JP6856639B2 (ja) ドリメノールシンターゼｉｉｉ
JP2019520845A (ja) アシル転移酵素の活性を有する微生物及びその用途
JPWO2019189724A5 (cg-RX-API-DMAC7.html)
JP5532928B2 (ja) セリン誘導体の製造方法及びこれに用いるタンパク質
JP5367300B2 (ja) 麹菌の分生子形成に関与する遺伝子、及び、麹菌の分生子形成能を増大させる方法
RU2018125950A (ru) Усиленная ферментация
RU2014137621A (ru) Способ уменьшения 1->2 сдвига рамки считывания